These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 8845826)
1. Pharmaceutical evaluation of carbamazepine suppositories in rats. Shinoda M; Akita M; Hasegawa M; Nadai M; Hasegawa T; Nabeshima T Biol Pharm Bull; 1995 Sep; 18(9):1289-91. PubMed ID: 8845826 [TBL] [Abstract][Full Text] [Related]
2. Utility of a rectal suppository containing the antiepileptic drug zonisamide. Nagatomi A; Mishima M; Tsuzuki O; Ohdo S; Higuchi S Biol Pharm Bull; 1997 Aug; 20(8):892-6. PubMed ID: 9300137 [TBL] [Abstract][Full Text] [Related]
3. Thermally reversible in situ gelling carbamazepine liquid suppository. El-Kamel A; El-Khatib M Drug Deliv; 2006; 13(2):143-8. PubMed ID: 16423803 [TBL] [Abstract][Full Text] [Related]
4. Decreased bioavailability of carbamazepine suppository after its intrarectal and intracolostomal administration to rectal-resected or colostoma-constructed rabbits. Nagasawa K; Nakanishi H; Yamamoto R; Kintsuji S; Fujimoto S Int J Pharm; 2002 Jul; 241(2):375-84. PubMed ID: 12100865 [TBL] [Abstract][Full Text] [Related]
5. [Study of Preparation and Utility of Suppository Containing Carbamazepine Tablet for Hospital Use in Rabbits]. Murata I; Arai N; Fukushima A; Saito A; Inoue Y; Kimura M; Kanamoto I Yakugaku Zasshi; 2015; 135(9):1049-55. PubMed ID: 26329551 [TBL] [Abstract][Full Text] [Related]
6. Studies on interactions between traditional herbal and Western medicines. I. Effects of Sho-seiryu-to on the pharmacokinetics of carbamazepine in rats. Ohnishi N; Yonekawa Y; Nakasako S; Nagasawa K; Yokoyama T; Yoshioka M; Kuroda K Biol Pharm Bull; 1999 May; 22(5):527-31. PubMed ID: 10375176 [TBL] [Abstract][Full Text] [Related]
7. [Morphine hydrochloride suppositories. I. Bioavailability of morphine hydrochloride suppositories in rats]. Tan T; Kojima K; Nakanishi Y; Arakawa S Yakugaku Zasshi; 1990 Jun; 110(6):426-33. PubMed ID: 2213529 [TBL] [Abstract][Full Text] [Related]
8. A single and multiple dose bioavailability study with carbamazepine 400 mg retard tablets with reference to enzyme autoinduction and circadian time differences. Hoffmann C; Zschiesche M; Franke G; Hoffmann A; Terhaag B; Möritz KU; Siegmund W Int J Clin Pharmacol Ther; 1997 Nov; 35(11):496-503. PubMed ID: 9401830 [TBL] [Abstract][Full Text] [Related]
9. Intravenous and oral pharmacokinetic evaluation of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions. Brewster ME; Anderson WR; Meinsma D; Moreno D; Webb AI; Pablo L; Estes KS; Derendorf H; Bodor N; Sawchuk R; Cheung B; Pop E J Pharm Sci; 1997 Mar; 86(3):335-9. PubMed ID: 9050802 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models. Fortuna A; Alves G; Soares-da-Silva P; Falcão A Epilepsy Res; 2013 Nov; 107(1-2):37-50. PubMed ID: 24050973 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of sustained release suppositories prepared with fatty base including solid fats with high melting points. Takatori T; Shimono N; Higaki K; Kimura T Int J Pharm; 2004 Jul; 278(2):275-82. PubMed ID: 15196632 [TBL] [Abstract][Full Text] [Related]
12. Replacing carbamazepine slow-release tablets with carbamazepine suppositories: a pharmacokinetic and clinical study in children with epilepsy. Arvidsson J; Nilsson HL; Sandstedt P; Steinwall G; Tonnby B; Flesch G J Child Neurol; 1995 Mar; 10(2):114-7. PubMed ID: 7782600 [TBL] [Abstract][Full Text] [Related]
13. [Morphine hydrochloride suppositories. II. Bioavailability of morphine hydrochloride suppositories in dogs]. Tan T; Kitamura K; Yamanaka M; Kojima K; Nakanishi Y; Arakawa S Yakugaku Zasshi; 1990 Jun; 110(6):434-41. PubMed ID: 2213530 [TBL] [Abstract][Full Text] [Related]
14. Prolonged release of morphine alkaloid from a lipophilic suppository base in vitro and in vivo. Morgan DJ; McCormick Y; Cosolo W; Roller L; Zalcberg J Int J Clin Pharmacol Ther Toxicol; 1992 Dec; 30(12):576-81. PubMed ID: 1473873 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and cognitive effects of carbamazepine formulations with different dissolution rates. Aldenkamp AP; Rentmeester T; Hulsman J; Majoie M; Doelman J; Diepman L; Schellekens A; Franken M; Olling M Eur J Clin Pharmacol; 1998 Apr; 54(2):185-92. PubMed ID: 9626926 [TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical evaluation of hollow type suppositories. IV. Improvement of bioavailability of propranolol in rabbits after rectal administration. Watanabe Y; Matsumoto Y; Baba K; Matsumoto M J Pharmacobiodyn; 1986 Jun; 9(6):526-31. PubMed ID: 3761140 [TBL] [Abstract][Full Text] [Related]
17. A limited sampling method for the estimation of AUC and Cmax of carbamazepine and carbamazepine epoxide following a single and multiple dose of a sustained-release product. Mahmood I; Chamberlin N Br J Clin Pharmacol; 1998 Mar; 45(3):241-6. PubMed ID: 9517367 [TBL] [Abstract][Full Text] [Related]
18. Absorption of phenytoin from rectal suppositories formulated with a polyethylene glycol base. Burstein AH; Fisher KM; McPherson ML; Roby CA Pharmacotherapy; 2000 May; 20(5):562-7. PubMed ID: 10809343 [TBL] [Abstract][Full Text] [Related]
19. Assessment of Biopharmaceutical Performance of Supersaturating Formulations of Carbamazepine in Rats Using Physiologically Based Pharmacokinetic Modeling. Thakore SD; Thakur PS; Shete G; Gangwal R; Narang AS; Sangamwar AT; Bansal AK AAPS PharmSciTech; 2019 Apr; 20(5):179. PubMed ID: 31041552 [TBL] [Abstract][Full Text] [Related]
20. Absorption and bioavailability of calcium and magnesium salts of indomethacin from rectal suppositories. Ogiso T; Iwaki M; Tamaki E J Pharmacobiodyn; 1984 Jun; 7(6):392-9. PubMed ID: 6548261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]